Deutsche Bank’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$108M Sell
550,899
-58,182
-10% -$11.3M 0.04% 456
2025
Q4
$106M Buy
609,081
+84,935
+16% +$15.5M 0.03% 455
2025
Q3
$99.9M Sell
524,146
-13,612
-3% -$2.42M 0.03% 456
2025
Q2
$96.6M Sell
537,758
-54,769
-9% -$9.51M 0.04% 448
2025
Q1
$100M Sell
592,527
-73,516
-11% -$12.1M 0.04% 431
2024
Q4
$100M Buy
666,043
+174,944
+36% +$27.2M 0.04% 432
2024
Q3
$76.2M Sell
491,099
-49,066
-9% -$7.33M 0.03% 487
2024
Q2
$73.9M Buy
540,165
+90,850
+20% +$12.4M 0.03% 442
2024
Q1
$59.8M Sell
449,315
-841
-0.2% -$109K 0.03% 504
2023
Q4
$62.1M Sell
450,156
-70,472
-14% -$9.26M 0.03% 461
2023
Q3
$63.4M Sell
520,628
-89,783
-15% -$12M 0.04% 405
2023
Q2
$85.8M Buy
610,411
+62,165
+11% +$8.57M 0.05% 369
2023
Q1
$77.6M Sell
548,246
-25,233
-4% -$3.61M 0.04% 389
2022
Q4
$89.7M Sell
573,479
-17,478
-3% -$2.51M 0.05% 348
2022
Q3
$72.5M Sell
590,957
-55,125
-9% -$7.26M 0.04% 378
2022
Q2
$85.9M Buy
646,082
+50,081
+8% +$6.82M 0.05% 358
2022
Q1
$81.6M Sell
596,001
-66,694
-10% -$9.3M 0.04% 427
2021
Q4
$115M Buy
662,695
+35,601
+6% +$5.42M 0.05% 343
2021
Q3
$91.1M Sell
627,094
-193,731
-24% -$28.3M 0.04% 407
2021
Q2
$108M Buy
820,825
+26,301
+3% +$3.44M 0.05% 352
2021
Q1
$102M Buy
794,524
+409,659
+106% +$50.5M 0.05% 346
2020
Q4
$45.9M Buy
384,865
+37,636
+11% +$4.59M 0.03% 533
2020
Q3
$39.8M Sell
347,229
-10,236
-3% -$1.21M 0.03% 515
2020
Q2
$40.7M Buy
357,465
+36,688
+11% +$3.89M 0.03% 493
2020
Q1
$25.8M Buy
320,777
+2,155
+0.7% +$223K 0.02% 570
2019
Q4
$34M Sell
318,622
-6,989
-2% -$729K 0.02% 599
2019
Q3
$34.8M Sell
325,611
-112,889
-26% -$11.6M 0.02% 591
2019
Q2
$44.6M Buy
438,500
+5,315
+1% +$511K 0.03% 615
2019
Q1
$38.9M Sell
433,185
-44,647
-9% -$3.87M 0.02% 679
2018
Q4
$39.8M Sell
477,832
-322,017
-40% -$30.2M 0.03% 586
2018
Q3
$86.3M Buy
799,849
+86,310
+12% +$9.47M 0.04% 435
2018
Q2
$78.4M Buy
713,539
+3,609
+0.5% +$376K 0.04% 483
2018
Q1
$71.2M Sell
709,930
-187,267
-21% -$19.2M 0.03% 509
2017
Q4
$88.4M Sell
897,197
-132,205
-13% -$12.5M 0.06% 365
2017
Q3
$96.4M Buy
1,029,402
+164,264
+19% +$17.4M 0.07% 333
2017
Q2
$96.2M Buy
865,138
+33,425
+4% +$3.53M 0.07% 320
2017
Q1
$81.7M Buy
831,713
+98,278
+13% +$9.37M 0.06% 365
2016
Q4
$67.4M Sell
733,435
-367,747
-33% -$31.7M 0.05% 394
2016
Q3
$93.2M Sell
1,101,182
-9,011
-0.8% -$757K 0.07% 336
2016
Q2
$90.4M Sell
1,110,193
-53,851
-5% -$4.1M 0.06% 341
2016
Q1
$83.2M Sell
1,164,044
-17,148
-1% -$1.15M 0.06% 349
2015
Q4
$84M Buy
1,181,192
+143,621
+14% +$9.66M 0.06% 360
2015
Q3
$63.8M Buy
1,037,571
+75,372
+8% +$5.27M 0.05% 429
2015
Q2
$69.8M Sell
962,199
-881,669
-48% -$65.1M 0.04% 448
2015
Q1
$142M Buy
1,843,868
+506,990
+38% +$36.3M 0.09% 269
2014
Q4
$89.6M Sell
1,336,878
-202,121
-13% -$12.8M 0.06% 404
2014
Q3
$93.4M Buy
1,538,999
+777,631
+102% +$47.9M 0.06% 359
2014
Q2
$44.7M Sell
761,368
-394,241
-34% -$23.1M 0.03% 572
2014
Q1
$66.9M Buy
1,155,609
+308,435
+36% +$16.5M 0.05% 437
2013
Q4
$45.4M Sell
847,174
-392,032
-32% -$23.3M 0.03% 530
2013
Q3
$76.6M Sell
1,239,206
-152,520
-11% -$9.13M 0.06% 368
2013
Q2
$84.4M Buy
+1,391,726
New +$82.9M 0.07% 316

Other funds holding DGX

Deutsche Bank's DGX Position: Q1 2026 in Review

Deutsche Bank reduced its Quest Diagnostics (DGX) stake by 9.6% in Q1 2026, selling an estimated $11.3M and leaving 550,899 shares worth $108M. The position accounts for 0.04% of the portfolio, ranked #456.

Deutsche Bank first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $142M in Q1 2015. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Deutsche Bank held 550,899 shares of Quest Diagnostics worth $108M as of Q1 2026.
  • Deutsche Bank sold 58,182 Quest Diagnostics shares in Q1 2026, an estimated $11.3M.
  • Quest Diagnostics made up 0.04% of Deutsche Bank's portfolio in Q1 2026, its #456 holding.
  • Deutsche Bank first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
  • Deutsche Bank's Quest Diagnostics position peaked at $142M in Q1 2015.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.